LeMaitre to Participate at Upcoming Investor Conferences in March

Rhea-AI Impact

(Low)

Rhea-AI Sentiment

(Neutral)

Rhea-AI Summary

LeMaitre Vascular (Nasdaq:LMAT) has announced its management team's participation in three major investor conferences this March 2025:

The 37th Annual ROTH Conference on March 17 at The Laguna Cliffs Marriott in Dana Point, CA, with a presentation scheduled for 4:00 PM PDT
The KeyBanc Healthcare Forum, a virtual event on March 19, presenting at 1:30 PM EDT
The Oppenheimer 35th Annual Healthcare MedTech & Services Conference, another virtual event on March 20, with a presentation time of 10:00 AM EDT

03/03/2025 - 05:06 PM

BURLINGTON, Mass., March 03, 2025 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that management will be participating in three upcoming investor conferences in March.

37^th Annual ROTH Conference
Monday, March 17, 2025
The Laguna Cliffs Marriott, Dana Point, CA
Management will present at 4:00 PM PDT

KeyBanc Healthcare Forum
Wednesday, March 19, 2025
Virtual Event
Management will present at 1:30 PM EDT

Oppenheimer 35^th Annual Healthcare MedTech & Services Conference
Thursday, March 20, 2025
Virtual Event
Management will present at 10:00 AM EDT

About LeMaitre

LeMaitre is a provider of devices, implants and services for the treatment of peripheral vascular disease, a condition that affects more than 200 million people worldwide. The Company develops, manufactures and markets disposable and implantable vascular devices to address the needs of its core customer, the vascular surgeon. Additional information can be found at www.lemaitre.com.

LeMaitre is a registered trademark of LeMaitre Vascular, Inc.

FAQ

What investor conferences will LeMaitre Vascular (LMAT) attend in March 2025?

LMAT will attend three conferences: ROTH Conference (March 17), KeyBanc Healthcare Forum (March 19), and Oppenheimer Healthcare Conference (March 20).